• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Inhibition of dihydrofolate reductase: structure-activity correlations of quinazolines based upon molecular shape analysis.

作者信息

Battershell C, Malhotra D, Hopfinger A J

出版信息

J Med Chem. 1981 Jul;24(7):812-8. doi: 10.1021/jm00139a009.

DOI:10.1021/jm00139a009
PMID:7277385
Abstract

A quantitative structure-activity relationship (QSAR) investigations of a set of 35 substituent-diverse quinazolines spanning an activity range of 4.16 log (1/I50) units was carried out using molecular shape analysis (MSA). I50 is the molar concentration necessary for 50% inhibiton of rat liver dihydrofolate reductase (DHFR). A correlation equation, analogous in descriptor form to those developed for two sets of 2,4-diaminotriazines which are also DHFR inhibitors, was constructed. The correlation coefficient, r, is 0.965, and the standard deviation, s, is 0.360. A second correlation equation was developed to explain the activities of the quinazolines on the basis of their shape similarity to a 2,4-diaminotriazine in its postulated active conformation as determined in a previous study. This correlation equation is again identical in descriptor form with those previously constructed for the triazines and quinazolines; r = 0.945 and s = 0.451 for this correlation equation. The ability to quantitatively explain activity in a congeneric set of compounds using a structurally diverse reference compound indicates the potential to design new lead compounds using MSA.

摘要

相似文献

1
Inhibition of dihydrofolate reductase: structure-activity correlations of quinazolines based upon molecular shape analysis.
J Med Chem. 1981 Jul;24(7):812-8. doi: 10.1021/jm00139a009.
2
Inhibition of dihydrofolate reductase: structure-activity correlations of 2,4-diamino-5-benzylpyrimidines based upon molecular shape analysis.二氢叶酸还原酶的抑制作用:基于分子形状分析的2,4-二氨基-5-苄基嘧啶的构效关系
J Med Chem. 1981 Jul;24(7):818-22. doi: 10.1021/jm00139a010.
3
Combined distance geometry analysis of dihydrofolate reductase inhibition by quinazolines and triazines.喹唑啉和三嗪对二氢叶酸还原酶抑制作用的联合距离几何分析
J Med Chem. 1983 Jul;26(7):996-1010. doi: 10.1021/jm00361a012.
4
Inhibition of dihydrofolate reductase. Structure-activity correlations of quinazolines.二氢叶酸还原酶的抑制作用。喹唑啉类的构效关系。
J Med Chem. 1976 May;19(5):605-11. doi: 10.1021/jm00227a006.
5
Quantitative structure-activity relationship by distance geometry: quinazolines as dihydrofolate reductase inhibitors.基于距离几何的定量构效关系:喹唑啉类作为二氢叶酸还原酶抑制剂
J Med Chem. 1982 Aug;25(8):892-9. doi: 10.1021/jm00350a003.
6
A molecular shape analysis and quantitative structure-activity relationship investigation of some triazine-antifolate inhibitors of Leishmania dihydrofolate reductase.
Arch Biochem Biophys. 1988 Oct;266(1):152-61. doi: 10.1016/0003-9861(88)90245-7.
7
Quantitative structure-activity relationships of antimalarial and dihydrofolate reductase inhibition by quinazolines and 5-substituted benzyl-2,4-diaminopyrimidines.喹唑啉类和5-取代苄基-2,4-二氨基嘧啶类化合物的抗疟活性及对二氢叶酸还原酶抑制作用的定量构效关系
J Med Chem. 1977 Jan;20(1):96-102. doi: 10.1021/jm00211a020.
8
General distance geometry three-dimensional receptor model for diverse dihydrofolate reductase inhibitors.用于多种二氢叶酸还原酶抑制剂的通用距离几何三维受体模型。
J Med Chem. 1984 Jul;27(7):901-14. doi: 10.1021/jm00373a016.
9
High-affinity inhibitors of dihydrofolate reductase: antimicrobial and anticancer activities of 7,8-dialkyl-1,3-diaminopyrrolo[3,2-f]quinazolines with small molecular size.
J Med Chem. 1996 Feb 16;39(4):892-903. doi: 10.1021/jm9505122.
10
Quinazolines as inhibitors of dihydrofolate reductase. 1.喹唑啉类作为二氢叶酸还原酶抑制剂。1.
J Med Chem. 1973 Jun;16(6):694-7. doi: 10.1021/jm00264a025.

引用本文的文献

1
Preparation of a Major Metabolite of Iguratimod and Simultaneous Assay of Iguratimod and Its Metabolite by HPLC in Rat Plasma.艾拉莫德主要代谢产物的制备及大鼠血浆中艾拉莫德及其代谢产物的HPLC同时测定
Iran J Pharm Res. 2019 Spring;18(2):631-641. doi: 10.22037/ijpr.2019.1100641.
2
Distance geometry analysis of ligand binding to drug receptor sites.配体与药物受体位点结合的距离几何分析。
J Comput Aided Mol Des. 1987 Oct;1(3):257-64. doi: 10.1007/BF01677048.